These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15982445)

  • 1. Altered gene expression in mice treated with the mood stabilizer sodium valproate.
    Chetcuti A; Adams LJ; Mitchell PB; Schofield PR
    Int J Neuropsychopharmacol; 2006 Jun; 9(3):267-76. PubMed ID: 15982445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray gene expression profiling of mouse brain mRNA in a model of lithium treatment.
    Chetcuti A; Adams LJ; Mitchell PB; Schofield PR
    Psychiatr Genet; 2008 Apr; 18(2):64-72. PubMed ID: 18349697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of mood stabilizer-regulated genes by differential-display PCR.
    Wang JF; Bown CD; Chen B; Young LT
    Int J Neuropsychopharmacol; 2001 Mar; 4(1):65-74. PubMed ID: 11343631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate, a mood stabilizer, induces WFS1 expression and modulates its interaction with ER stress protein GRP94.
    Kakiuchi C; Ishigaki S; Oslowski CM; Fonseca SG; Kato T; Urano F
    PLoS One; 2009; 4(1):e4134. PubMed ID: 19125190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons.
    Wang JF; Shao L; Sun X; Young LT
    J Neurochem; 2004 Mar; 88(6):1477-84. PubMed ID: 15009649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
    J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1.
    Plant KE; Anderson E; Simecek N; Brown R; Forster S; Spinks J; Toms N; Gibson GG; Lyon J; Plant N
    Toxicol Appl Pharmacol; 2009 Feb; 235(1):124-34. PubMed ID: 19101580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic valproate normalizes behavior in mice overexpressing calcineurin.
    Herzog CJ; Miot S; Mansuy IM; Giros B; Tzavara ET
    Eur J Pharmacol; 2008 Feb; 580(1-2):153-60. PubMed ID: 18021766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential display PCR reveals novel targets for the mood-stabilizing drug valproate including the molecular chaperone GRP78.
    Wang JF; Bown C; Young LT
    Mol Pharmacol; 1999 Mar; 55(3):521-7. PubMed ID: 10051536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate improves prepulse inhibition deficits induced by corticotropin-releasing factor independent of GABA(A) and GABA(B) receptor activation.
    Douma TN; Millan MJ; Verdouw PM; Oosting RS; Olivier B; Groenink L
    Neuropharmacology; 2014 Apr; 79():66-74. PubMed ID: 24211652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mood stabilizers on gene expression in lymphoblastoid cells.
    Sugawara H; Iwamoto K; Bundo M; Ishiwata M; Ueda J; Kakiuchi C; Ishigooka J; Kato T
    J Neural Transm (Vienna); 2010 Feb; 117(2):155-64. PubMed ID: 19949822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mood-stabilizers differentially affect housekeeping gene expression in human cells.
    Powell TR; Powell-Smith G; Haddley K; Mcguffin P; Quinn J; Schalkwyk LC; Farmer AE; D'Souza UM
    Int J Methods Psychiatr Res; 2014 Jun; 23(2):279-88. PubMed ID: 24677680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium-myo-inositol co-transporter (SMIT-1) mRNA is increased in neutrophils of patients with bipolar 1 disorder and down-regulated under treatment with mood stabilizers.
    Willmroth F; Drieling T; Lamla U; Marcushen M; Wark HJ; van Calker D
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):63-71. PubMed ID: 16420717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach.
    Ogden CA; Rich ME; Schork NJ; Paulus MP; Geyer MA; Lohr JB; Kuczenski R; Niculescu AB
    Mol Psychiatry; 2004 Nov; 9(11):1007-29. PubMed ID: 15314610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of valproate.
    Owens MJ; Nemeroff CB
    Psychopharmacol Bull; 2003; 37 Suppl 2():17-24. PubMed ID: 14624230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: Potential involvement of epigenetics.
    Pisanu C; Papadima EM; Del Zompo M; Squassina A
    Neurosci Lett; 2018 Mar; 669():24-31. PubMed ID: 27343410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells.
    Wang J; Michelhaugh SK; Bannon MJ
    Eur J Neurosci; 2007 Apr; 25(7):1982-6. PubMed ID: 17439486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate and neuroprotective effects for bipolar disorder.
    Atmaca M
    Int Rev Psychiatry; 2009; 21(4):410-3. PubMed ID: 20374154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-type specific regulation of calreticulin and Bcl-2 expression by mood stabilizer drugs.
    Corson TW; Woo KK; Li PP; Warsh JJ
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):143-50. PubMed ID: 15013030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prolonged phenytoin administration on rat brain gene expression assessed by DNA microarrays.
    Mariotti V; Melissari E; Amar S; Conte A; Belmaker RH; Agam G; Pellegrini S
    Exp Biol Med (Maywood); 2010 Mar; 235(3):300-10. PubMed ID: 20404047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.